If you need more lookups,
subscriptions start at $34 USD/month.
Mark Goldberg Location
Brookline, MA, US
Mark Goldberg Work
Member, Board of Directors (NED) @ (August 2021 - Present)
Member, Board of Directors @ (March 2020 - Present)
Vice Chair National Board of Directors @ (April 2025 - Present)
Member National Board of Directors @ (January 2019 - Present)
Member, Eastern New England Board @ (July 2017 - Present)
Chair, Eastern New England Board @ (July 2017 - March 2020)
Member of the Board, New England Division @ (January 2010 - June 2017)
Member of the Board of Directors @ (January 2015 - July 2025)
Lecturer @ (January 2021 - June 2025)
Associate Professor @ (July 1996 - December 2021)
Assistant Professor @ (July 1989 - June 1996)
Instructor @ (June 1987 - June 1989)
Attending Physician, Hematology Division @ (July 1987 - June 2025)
Member of the Board of Directors @ (July 2014 - February 2025)
Member of the Board of Directors @ (November 2011 - February 2024)
Member of the Board of Directors @ (March 2014 - September 2022)
Member Board Of Directors @ (December 2017 - January 2020)
Member of the Board of Directors @ (January 2015 - December 2017)
Advisor, Medical and Regulatory Strategy @ (September 2014 - June 2015)
EVP Medical and Regulatory Strategy @ (January 2014 - September 2014)
SVP Medical and Regulatory Affairs @ (September 2011 - January 2014)
Member Board Of Directors @ (January 2008 - November 2011)
SVP Clinical Development @ Genzyme Corporation (November 1996 - July 2011)
Mark Goldberg Education
Harvard Medical School
Doctor of Medicine (MD)
1976-1981
Harvard University
Bachelor of Arts (B.A.) (Biochemistry and Molecular Biology)
1972-1976
Mark Goldberg Skills
Biotechnology
Clinical Development
Biopharmaceuticals
Regulatory Affairs
Oncology
Clinical Trials
Immunology
Drug Development
Drug Discovery
Infectious Diseases
Pharmaceutical Industry
Commercialization
Assay Development
CRO
Molecular Biology
Lifesciences
Product Launch
CTMS
Technology Transfer
GCP
Medical Affairs
FDA
Biomarkers
IND
Regulatory Submissions
21 CFR Part 11
Genomics
Hematology
Cell Culture
Cancer
Medical Devices
Sop
Monoclonal Antibodies
Vaccines
Life Sciences
Standard Operating Procedure (SOP)
CRO Management
Good Clinical Practice (GCP)
U.S. Food and Drug Administration (FDA)
Research
Clinical Research
Clinical Trial Management System Ctms
Microsoft Word
Standard Operating Procedure Sop
Medicine
u.s. Food and Drug Administration Fda
Healthcare
Good Clinical Practice Gcp
Directors
Customer Service
Project Management
Microsoft Office
Standard Operating Procedure
Good Clinical Practice
u.s. Food and Drug Administration
Clinical Trial Management System
Mark Goldberg Summary
Mark Goldberg, based in Brookline, MA, US, is currently a Member, Board of Directors (NED) at AVACTA GROUP PLC. Mark Goldberg brings experience from previous roles at Walden Biosciences and American Cancer Society. Mark Goldberg holds a 1976 - 1981 Doctor of Medicine (MD) @ Harvard Medical School. With a robust skill set that includes Biotechnology, Clinical Development, Biopharmaceuticals, Regulatory Affairs, Oncology and more. Mark Goldberg has 2 emails and 1 mobile phone numbers on RocketReach.
Looking for a different Mark Goldberg?
Find contact details for 700 million professionals.